Skip to main content

Table 3 Primary endpoint: safety

From: A-Part Gel, an adhesion prophylaxis for abdominal surgery: a randomized controlled phase I–II safety study [NCT00646412]

 

A-Part-Gel (N = 31)

Control (N = 29)

Wound healing impairment and /or peritonitis

2 (6.5 %)

4 (13.8 %)

90% CI [0.012, 0.189]

90 % CI [0.049, 0.288]

Peritonitis

1 (3.2 %)

0 (0.0 %)

90 % CI [0.002, 0.144]

90 % CI [0.000, 0.098]

Delayed wound healing

2 (6.5 %)

4 (13.8 %)

90 % CI [0.012, 0.189]

90 % CI [0.049, 0.288]

Surgical site infection

1 (3.2 %)

3 (10.3 %)

90 % CI [0.002, 0.144]

90 % CI [0.029, 0.249]

Impaired wound healing

2 (6.5 %)

4 (13.8 %)

90 % CI [0.012, 0.189]

90 % CI [0.049, 0.288]

Anastomotic leakage

3 (9.7 %)

3 (10.3 %)

90 % CI [0.027, 0.232]

90 % CI [0.029, 0.246]